Skip to Content
Merck
CN
  • Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.

Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.

Bioorganic & medicinal chemistry (2008-07-04)
Anna Minarini, Gabriella Marucci, Cristina Bellucci, Gianluca Giorgi, Vincenzo Tumiatti, Maria Laura Bolognesi, Riccardo Matera, Michela Rosini, Carlo Melchiorre
ABSTRACT

Pirenzepine (2) is one of the most selective muscarinic M(1) versus M(2) receptor antagonists known. A series of 2 analogs, in which the piperazyl moiety was replaced by a cis- and trans-cyclohexane-1,2-diamine (3-6) or a trans- and cis-perhydroquinoxaline rings (7 and 8) were prepared, with the aim to investigate the role of the piperazine ring of 2 in the interaction with the muscarinic receptors. The structural change leading to compounds 3-6 abolished in binding assays the muscarinic M(1)/M(2) selectivity of 2, due to an increased M(2) affinity. Rather, compounds 3-6 displayed a reversed selectivity showing more affinity at the muscarinic M(2) receptor than at all the other subtypes tested.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-trans-1,2-Diaminocyclohexane, 99%
Sigma-Aldrich
(1R,2R)-(−)-1,2-Diaminocyclohexane, 98%
Sigma-Aldrich
(1S,2S)-(+)-1,2-Diaminocyclohexane, 98%
Sigma-Aldrich
1,2-Diaminocyclohexane, mixture of cis and trans, 99%